Limbix is developing a pipeline of prescription digital therapeutics (PDTs) for adolescent mental health disorders. We are passionate about creating evidence-based digital programs to increase young people’s access to clinically effective mental health treatment. Our first product, SparkRx, is a CBT-based digital therapeutic to treat symptoms of depression in teens and young adults.
SparkRx is a digital therapeutic that provides the core components of behavioral activation therapy to adolescents aged 13-22 with symptoms of depression. The 5-week program provides clinicians with an immediate, safe and discreet adjunct treatment option they can offer their patients, overcoming common barriers to finding mental health care. SparkRx is delivered via a smartphone app, and includes features such as psychoeducation, mood tracking, activity scheduling, problem solving and mindfulness.
AAP Nat Con